Serologic angiogenesis factors and microvascular density in renal cell carcinoma: two independent parameters.

Abstract:

:Renal Cell Carcinoma (RCC) is characterized by high intratumoral microvascular density (iMVD) and significantly elevated serologic titers of angiogenesis factors, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (vEGF) and angiogenin (Ag). The goal of the present study was to find whether a correlation exists between any of these factors and intratumoral microvascular density (iMVD). Serologic angiogenesis factors were determined directly before nephrectomy of a tumorous kidney in 12 patients (average age: 67.6 years [49-78] with localized clear-cell RCC (Robson I-II) (Quantikine', R&D Systems Europe, Abington, UK). Sections were taken in each case from the microscopically most aggressive area of the tumorous kidney preparations. Staining was carried out with a primary antibody against CD31 (DAKO M 0823, Hamburg, Germany). iMVD was counted at 160x magnification at five "hot spots" 200 x 200 microns in size, and the individual factors were then correlated with the areas of maximum and average iMVD (iMVDmax, iMVD-d). Average concentrations of 38 pg/ml +/- 68 were found for bFGF, 712 pg/ml +/- 791 for vEGF, and 358 ng/ml +/- 97 for Ag. iMVDmax was 20 +/- 11 per area, iMVD-d was 410/mm2 +/- 243. No correlation was found between microvascular density and serologic angiogenesis factors for any parameter. Actual tumor vascularization, expressed as iMVD, was not correlated with the 3 angiogenesis parameters which were studied. On the one hand, this raises the question whether angiogenesis can be measured at all with these parameters; on the other, it remains nuclear whether the continuous process of angiogenesis can be registered at all by chronologic, specific factor analysis.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Wechsel HW,Feil G,Bichler KH,Beiter T,Gleichmann R

subject

Has Abstract

pub_date

2000-11-01 00:00:00

pages

5117-20

issue

6D

eissn

0250-7005

issn

1791-7530

journal_volume

20

pub_type

杂志文章
  • Comparison of In Vitro Antileukemic Activity of 4-Hydroperoxyifosfamide and 4-Hydroperoxycyclophosphamide.

    abstract:BACKGROUND/AIM:The oxazaphosphorines, ifosfamide and cyclophosphamide, represent a class of alkylating agents. The aim of the present in vitro study was to compare antileukemic activity of 4-hydroperoxyifosfamide (4-OOH-IF) and 4-hydroperoxycyclophosphamide (4-OOH-CP). MATERIALS AND METHODS:The experiments were perfor...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12088

    authors: Opydo-Chanek M,Śladowska K,Blicharski K,Mikeš J,Fedoročko P,Niemeyer U,Mazur L

    更新日期:2017-11-01 00:00:00

  • Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.

    abstract::During postnatal development, the formation of new blood vessels is possible only through angiogenesis. The initial growth of solid neoplasms, including childhood brain tumors, during the genetically determined stages of carcinogenesis, even at clinically undetectable sizes (a few mm3), depends upon the continuous for...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bodey B,Bodey B Jr,Siegel SE,Kaiser HE

    更新日期:1998-05-01 00:00:00

  • Identification of breast cancer metastasis-associated genes by chip technology.

    abstract::In order to identify genes associated with metastasis of mammary carcinoma, we compared the transcriptional profile (Affymetrix chip technology) of two cell lines derived from primary mammary carcinoma, three cell lines derived from bone marrow micrometastasis, a cell line derived from a lymph node metastasis as well ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Evtimova V,Schwirzke M,Tarbé N,Burtscher H,Jarsch M,Kaul S,Weidle UH

    更新日期:2001-11-01 00:00:00

  • Initial Results of Hypofractionated Carbon Ion Radiotherapy for Cholangiocarcinoma.

    abstract:AIM:To report initial results of hypofractionated carbon ion radiotherapy (C-ion RT) for cholangiocarcinoma. PATIENTS AND METHODS:Data regarding seven patients with cholangiocarcinoma treated by C-ion RT were analyzed. Prescribed doses were 52.8 Gy [relative biological effectiveness (RBE)] or 60.0 Gy (RBE) in four fra...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Abe T,Shibuya K,Koyama Y,Okamoto M,Kiyohara H,Katoh H,Shimada H,Kuwano H,Ohno T,Nakano T

    更新日期:2016-06-01 00:00:00

  • Evaluation of a possible styrene-induced damage to the haematopoietic tissues in the rat.

    abstract::The aim of this study was to determine a possible risk of malignancies in the haematopoietic tissues of rats treated with styrene, either by injection or by inhalation. Two experiments were carried out: in the first (acute treatment), 12 male rats were treated intraperitoneally with different doses of styrene (40 mg/K...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nano R,Rossi A,Fenoglio C,de Piceis Polver P

    更新日期:2000-05-01 00:00:00

  • Virtual Screening of 1,4-Naphthoquinone Derivatives for Inhibition of a Key Cancer Signaling Protein, AKT1 Kinase.

    abstract:BACKGROUND/AIM:AKT, also known as protein kinase B (PKB), is an established therapeutic target in cancer and its inhibitors are increasingly designed. The anti-cancer potential of a compound class naphthoquinones has been constantly realized. The current work aimed to explore AKT1 inhibitors from 1,4-naphthoquionone de...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13532

    authors: Rehan M,Mostafa M

    更新日期:2019-07-01 00:00:00

  • Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.

    abstract:BACKGROUND:Mifepristone has been demonstrated to improve longevity and quality of life in mice with spontaneous murine cancer without progesterone receptors and in human colon cancer. The present study evaluated the palliative effect of mifepristone in a variety of different types of human cancer. PATIENTS AND METHODS...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Check JH,Dix E,Cohen R,Check D,Wilson C

    更新日期:2010-02-01 00:00:00

  • Novel mutations in the APC gene and clinical features in Swedish patients with polyposis coli.

    abstract::The adenomatous polyposis coli (APC) gene was investigated in Swedish patients with familial adenomatous polyposis (FAP). A combination of analyses including single stranded conformation polymorphism (SSCP), heteroduplex (HD), protein truncation test (PTT) and direct sequencing was used to enable optimal mutation dete...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nordling M,Engwall Y,Wahlström J,Wiklund L,Eriksson MA,Gustavsson B,Fasth S,Larsson PA,Martinsson T

    更新日期:1997-11-01 00:00:00

  • Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study.

    abstract:AIM:To evaluate the efficacy and toxicities of cisplatin and daily oral etoposide in patients with recurrent cervical cancer. PATIENTS AND METHODS:Treatment was initiated with oral etoposide 25 mg/day for 21 consecutive days, with intravenous cisplatin at 50 mg/m², on day 1, every 4 weeks, then the etoposide dose was ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Watanabe Y,Hoshiai H,Nakanishi T,Kawamura N,Tanaka N,Isaka K,Kamiura S,Ohmichi M,Hatae M,Ochiai K

    更新日期:2011-09-01 00:00:00

  • Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems.

    abstract::The immunomodulatory and antimetastatic/antitumor activity of thymic humoral factor-gamma 2 (THF-gamma 2) was evaluated in BALB/c-mice. Daily subcutaneous applications (7 consecutive days, 20, 200 ng of THF-gamma 2 per injection/mouse) upregulated counts of thymocytes and peripheral blood cells in tumor bearing mice. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Beuth J,Schierholz JM,Mayer G,Keisari Y

    更新日期:2000-11-01 00:00:00

  • Molecular mechanisms governing melanogenesis in hamster melanomas: relative abundance of tyrosinase and catalase-B (gp 75).

    abstract::Variants of the Bomirski family of hamster melanomas whose proliferative rates differ inversely with the genetically determined degree of melanogenesis were probed for two proteins critical in melanogenesis: tyrosinase and catalase-B (gp 75). The parental black tumor Ma contained both proteins in abundance. The amelan...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Slominski A,Costantino R,Howe J,Moellmann G

    更新日期:1991-01-01 00:00:00

  • Cellular events during invasion by tumor cells of chick embryo skin.

    abstract::Tumor cell invasion was studied using the 9-day chick embryo skin (CES). The invasion process was broken down into 4 sequential events: adhesion, penetration, proliferation and colonization. Tumor cells used in this study included cells from various human and canine solid tumors, tumor cell lines from human and animal...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Katoh A,Charoensiri S

    更新日期:1989-01-01 00:00:00

  • Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's diseases and their relation to proliferation and apoptosis.

    abstract:BACKGROUND:Human herpesviruses types 4 and 6 (EBV, HHV-6) are frequently found in Hodgkin 's disease (HD) and--to a certain extent--in Kikuchi-Fujimoto's disease (KFD). Both viruses are apparently related to proliferative and/or apoptotic processes as represented by HD or KFD respectively. OBJECTIVE:To correlate frequ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Krueger GR,Huetter ML,Rojo J,Romero M,Cruz-Ortiz H

    更新日期:2001-05-01 00:00:00

  • Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer.

    abstract:BACKGROUND:We report the prognostic significance of peripheral and tumor-infiltrating Th1, Th2, Tc1 and Tc2 cells in lung cancer patients. MATERIALS AND METHODS:We evaluated the rates of interferon (IFN)-gamma+/CD4+ cells (Th1), interleukin (IL)-4+ /CD4+ cells (Th2), IFN-gamma+/CD8+ cells (Tc1), IL-4+ /CD8+ cells (Tc2...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ito N,Suzuki Y,Taniguchi Y,Ishiguro K,Nakamura H,Ohgi S

    更新日期:2005-05-01 00:00:00

  • Sulindac induces apoptosis, inhibits proliferation and activates caspase-3 in Hep G2 cells.

    abstract:BACKGROUND:It has recently been reported that sulindac has an apoptotic effect on KYN-2 cells, an undifferentiated hepatoma cell line. The present work investigates whether sulindac also has an apoptotic effect on well-differentiated hepatoma cells and what its potential mechanism might be. MATERIALS AND METHODS:Hep G...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Liu JJ,Wang JY,Hertervig E,Nilsson A,Duan RD

    更新日期:2002-01-01 00:00:00

  • Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.

    abstract::We have previously reported that the presence of an extracapsular invasion (ECI) at sentinel lymph nodes (SLNs) is a strong predictor of non-SLN metastasis in breast cancer. We hypothesized that(18)F-fluorodeoxyglucose (FDG) uptake by metastatic SLNs reflects invasive disease, or ECI. In this study, we evaluated the a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fujii T,Yajima R,Tatsuki H,Kuwano H

    更新日期:2016-04-01 00:00:00

  • Attempt to modify Rauscher-virus leukemogenesis by modulation of lymphoreticular and hematopoietic tissue.

    abstract::Rauscher erythroleukemia virus of the mouse was originally isolated from an animal bearing a lymphocytic neoplasm. In order to control extraneous influences on leukemia development, we modulated thymus-dependent and bursa-dependent lymphatic tissues and the granulopoietic and erythropoietic components of hemoreticular...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Henkel B,Krueger GR

    更新日期:1986-07-01 00:00:00

  • Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.

    abstract:BACKGROUND/AIM:Pelvic exenteration is a radical procedure for certain advanced or recurrent gynaecological cancers, performed with curative or palliative intent. Its validity has evolved as operative mortality and morbidity have improved. This surgery was evaluated to determine the validity of these claims. PATIENTS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13759

    authors: Soeda S,Furukawa S,Sato T,Ueda M,Kamo N,Endo Y,Kojima M,Nomura S,Kataoka M,Fujita S,Endo H,Takahashi T,Watanabe T,Yamada H,Fujimori K

    更新日期:2019-10-01 00:00:00

  • Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.

    abstract:BACKGROUND:The search for biological markers to predict malignant disease and its recurrence, or to monitor the effectiveness of treatment is a continuous process in medicine. Several years ago, urinary excretion of cGMP in urine was found to be a sensitive predictor in the follow-up of ovarian cancer and of monitoring...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Orbo A,Hanevik M,Jaeger R,Van Heusden S,Sager G

    更新日期:2007-07-01 00:00:00

  • Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer.

    abstract:BACKGROUND:Metastatic breast cancer remains a major clinical issue despite progress achieved in recent years. Three randomised trials have demonstrated the benefit of combining bevacizumab with various taxane schedules. Herein, this study sought to investigate an alternative bevacizumab-taxane regimen as first-line tre...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kountourakis P,Doufexis D,Maliou S,Karagiannis A,Kardara E,Margari C,Sykoutri D,Tzovaras A,Ardavanis A

    更新日期:2010-07-01 00:00:00

  • Pros and cons for systemic therapy in recurrent ovarian cancer.

    abstract::Due to the high recurrence rates of ovarian carcinoma, the treatment of recurrent disease is currently one of the most challenging topics in the clinical setting. Ovarian cancer patients who do not respond to initial chemotherapy or who relapse after achieving a response are generally incurable. Treatment goals after ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Oskay-Ozcelik G,Sehouli J

    更新日期:2009-07-01 00:00:00

  • Lentinan potentiates immunity and prolongs the survival time of some patients.

    abstract::For the selection of patients responding well to lentinan, we performed two immunological analysis of patients. Flow cytometric analysis was obtained from peripheral blood lymphocytes; the patients who had greater than 2.5 ratio of [CD11(-) CD8(+)/CD11(+) CD8(+) after treatment]/[CD11(-) CD8(+)/CD11(+) CD8(+) before t...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Matsuoka H,Seo Y,Wakasugi H,Saito T,Tomoda H

    更新日期:1997-07-01 00:00:00

  • Hypoxia Stimulates the Epithelial-to-Mesenchymal Transition in Lung Cancer Cells Through Accumulation of Nuclear β-Catenin.

    abstract:BACKGROUND/AIM:Recent studies implied a significant role of hypoxia-inducible factor-1α (HIF1α) in cell transformation. This study aimed to assess the effects of HIF1α on the epithelial-to-mesenchymal transition (EMT) and tumorigenesis of lung adenocarcinoma cells. MATERIALS AND METHODS:Invasion, migration and colony ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12986

    authors: Liu KH,Tsai YT,Chin SY,Lee WR,Chen YC,Shen SC

    更新日期:2018-11-01 00:00:00

  • Clinical Efficacy of Carbon Ion Radiotherapy for Unresectable Chondrosarcomas.

    abstract:BACKGROUND:Carbon ion radiotherapy has precise dose distribution and high biological effectiveness and is likely a promising therapy for patients with sarcomas. We evaluated the outcomes of carbon ion radiotherapy in patients with unresectable chondrosarcomas. PATIENTS AND METHODS:A retrospective analysis of 75 tumors...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12162

    authors: Imai R,Kamada T,Araki N,WORKING GROUP FOR BONE and SOFT-TISSUE SARCOMAS.

    更新日期:2017-12-01 00:00:00

  • Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer.

    abstract:BACKGROUND/AIM:The expression of corticotropin-releasing hormone (CRH)-related peptides involved in stress response in colorectal cancer has been reported. We examined the involvement of CRH-related peptides in cellular stress caused by anticancer drugs in colorectal cancer. MATERIALS AND METHODS:Changes in the expres...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14455

    authors: Kuwata GO,Ikeda K,Manome Y

    更新日期:2020-08-01 00:00:00

  • Is pancreatic resection justified for metastasis of papillary thyroid cancer?

    abstract:BACKGROUND:This case report describes a patient with symptomatic anaemia due to a bleeding duodenal metastasis from metastasising differentiated thyroid cancer (DTC), which was treated by partial duodenopancreatectomy (DP). CASE REPORT:A 71-year old male was sent to hospital with severe anaemia. This patient had suffe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Meyer A,Behrend M

    更新日期:2006-05-01 00:00:00

  • Identification of a 35 kD tumor-associated autoantigen in papillary thyroid carcinoma.

    abstract::Despite its tendency to metastasize and grow multifocally, papillary thyroid carcinoma (PTC), the most common endocrine malignancy, usually displays an indolent clinical course. Although this behavior probably reflects the inherent low growth potential of PTC cells, it has been postulated that the striking inflammator...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lucas SD,Ek B,Rask L,Rastad J,Akerström G,Juhlin C

    更新日期:1996-09-01 00:00:00

  • Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis.

    abstract:BACKGROUND:Tumor budding and a proficient mismatch repair (pMMR) status are considered adverse prognostic factors in colorectal cancer (CRC). The aim of this pilot study was to assess tumor budding in primary CRC with pMMR versus that with deficient mismatch repair (dMMR). MATERIALS AND METHODS:Tumor budding was retro...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.21873/anticanres.12778

    authors: Karlberg M,Stenstedt K,Hallström M,Ragnhammar P,Lenander C,Edler D

    更新日期:2018-08-01 00:00:00

  • Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.

    abstract:BACKGROUND:Matrix metalloproteinases (MMPs) are involved with tumour invasion and metastasis. Controversial data exists concerning the prognostic value of MMP-9 in breast carcinoma. We examined, here, whether the MMP-9 immunoreactive protein would correlate with--the prognosis in breast carcinoma treated with hormonal ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rahko E,Jukkola A,Melkko J,Paavo P,Bloigu R,Talvensaari-Mattila A,Turpeenniemi-Hujanen T

    更新日期:2004-11-01 00:00:00

  • Enhancement of anticancer effects of radiation and conventional anticancer agents by a quinolinone derivative, vesnarinone: studies on human gastric cancer tissue xenografts in nude mice.

    abstract::Vesnarinone (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone), a quinolinone derivative, is an orally active inotropic agent used in Japan for the treatment of chronic heart failure. Recently, it has been reported that vesnarinone induces differentiation and apoptosis in certain types of leuk...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawai K,Konishi Y,Izumi K,Sato M,Adachi M,Hozumi M

    更新日期:1998-01-01 00:00:00